Nε-(1-carboxyethyl)-L-lysine
Nε-(1-carboxyethyl)-L-lysine has been studied in 1 paper since 2023: 1 observational study in people. The newest paper, Aug 8, 2023: “Higher dietary advanced glycation products intake is associated with increased risk of dementia, independent from genetic predisposition”.
1 paper studies it1 findingUpdated
See all 1 papers on nε-(1-carboxyethyl)-L-lysine
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“Higher intakes of dietary AGEs including CEL, CML and MG-H1 were associated with a higher risk of dementia”
- 1 lab in 1 country
- Funders: National Natural Science Foundation of China and 1 more
- Humans1
What is nε-(1-carboxyethyl)-L-lysine linked with?
1Studies link nε-(1-carboxyethyl)-L-lysine with dementia.
Dementia
upin humans1HR 1.53
1 study
Dementia
upin humans1HR 1.53
Nε-(1-carboxyethyl)-L-lysine is associated with dementia in humans (Free from dementia at baseline; multivariable-adjusted analysis) (HR 1.53, 95% CI 1.25–1.89).
“Higher intakes of dietary AGEs including CEL, CML and MG-H1 were associated with a higher risk of dementia”
HumansFree from dementia at baseline; multivariable-adjusted analysisHighest versus lowest tertile of intakeMedian follow-up of 11.9 yearsn = 93,830
Clinical nutrition (Edinburgh, Scotland)